Natalie Matosin
Quick Facts
Biography
Dr Natalie Matosin is an Australian scientist known for research into the causes of stress and its role in mental illness. Matosin's research has been published in academic journals, as well as on The Conversation. Matosin spoke at TEDx Hamburg in June 2017 and is a National Health and Medical Research Council CJ Martin Early Career Research Fellow.
Early life and education
Matosin was interested in science and curing the world of disease from an early age and went on to study a Bachelor of Medical Science at university. Matosin was awarded a PhD from the University of Wollongong in 2015 with a thesis "Exploring mGluR5 dysregulation in schizophrenia: from gene to protein" under the direction ofKelly A Newell.She went on to hold a postdoc position at UNSW.
Career and research
Matosinworks at the University of Wollongong and the Max Planck Institute of Psychiatry in Germany. Matosin was working in Germany during the arrival of large numbers of Syrian refugees, and her research now includes study into the impact of trauma on refugee populations, examining its impact on the body's physiology at a molecular level and its relationship to mental illness.
Publication
Her most cited articles are:
- Matosin, Natalie, Elisabeth Frank, Martin Enge, Jeremy S. Lum, and Kelly A. Newell "Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture." Disease Models & Mechanisms (2014) 7, 171-173 doi:10.1242/dmm.015123:(cited 114 times according to Google Scholar )
- Matosin N, Newell KA. Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia. Neuroscience & Biobehavioral Reviews. 2013 Mar 1;37(3):256-68. (cited 58 times according to Google Scholar )
- Matosin N, Fernandez-Enright F, Frank E, Deng C, Wong J, Huang XF, Newell KA. Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics. Journal of psychiatry & neuroscience: JPN. 2014 Nov;39(6):407. (cited 41 times according to Google Scholar )
Recognition and awards
- 2016 NHMRC CJ Martin Early Career Fellowship, Australian National Health and Medical Research Council.
- 2017 place on Forbes 30 Under 30 list in the category Europe - Science & Healthcare.
- 2017 Alies Muskin Career Development Award, Anxiety and Depression Association of America.